Abstract
Both marijuana and the hallucinogens produce a change in the level of consciousness, and both are capable of inducing hallucinations. However, in the usual doses taken, the predominant effect of cannabis is to alter the “feeling state” without frank hallucinations, whereas the drugs discussed in this chapter produce abnormal sensory inputs of a predominantly visual nature (illusions or hallucinations) even at low doses.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ludwig, A. M., Levine, J., & Stark, L. H. LSD and Alcoholism. A Clinical Study Springfield, Ill.: Charles C Thomas, 1970, pp. 13–28, 40–98, 233–244.
Dorrance, D. L., Janiger, O., & Teplitz, R. L. Effect of peyote on human chromosomes. Cytogenetic study of the Huichol Indians of Northern Mexico. Journal of American Medical Association. 234(3): 299–302, 1975.
Dobkin de Rios, M. Man, culture and hallucinogens: An overview. In V. Rubin (Ed.), Cannabis and Culture. The Hague: Mouton, 1975.
Hofmann, F. G., & Hofmann, A. D. A Handbook on Drug and Alcohol Abuse. New York: Oxford University Press, 1975, pp. 152–174.
Vogel, W. H., & Evans, B. D. Minireview. Structure-activity-relationships of certain hallucinogenic substances based on brain levels. Life Sciences. 20: 1629–1636, 1977.
Jaffe, J. H. Drug addiction and drug abuse. In L. S. Goodman & A. Gilman (Eds.), The Pharmacological Basis of Therapeutics. New York: Macmillan, 1975, pp. 284–324.
Solursh, L. P. Emergency treatment of acute adverse reactions to hallucinogenic drugs. In P. G. Bourne (Ed.), A Treatment Manual for Acute Drug Abuse Emergencies. Washington, D.C.: U.S. Government Printing Office, 1974, pp. 77–79.
Medical Letter. Diagnosis and management of reactions to drug abuse. 19(3): 13–16, 1977.
Ungerleider, J. T., & Frank, I. M. Emergency treatment of adverse reactions to hallucinogenic drugs. In P. G. Bourne (Ed.), A Treatment Manual for Acute Drug Abuse Emergencies. Washington, D.C.: U.S. Government Printing Office, 1974, pp. 73–76.
Carino, M. A., & Horita, A. Rapid development of tolerance upon central injection of LSD. Life Sciences. 20: 49–56, 1977.
Cohen, S. (Ed.). Pharmacology of drugs of abuse. Drug Abuse and Alcoholism Newsletter. 5(6):1–4, 1976.
Brown, J. K., & Malone, M. H. Some U.S. street drug identification programs. Journal of American Pharmaceutical Association. 13(12): 670–6675, 1973.
Bowers, M. B., Jr. Psychoses precipitated by psychotomimetic drugs. A follow-up study. Archives of General Psychiatry. 34: 832–835, 1977.
Blackford, L. Student Drug Surveys-San Mateo County, California, 1968–1975. San Mateo County Dept. of Public Health and Welfare, 225–37th Ave., San Mateo, Calif. 94403, 1975.
Shapira, J., & Cherubin, C. E. Drug Abuse: A Guide for the Clinician. New York: American Elsevier, 1975, p. 368.
Taylor, R. L., Maurer, J. I., & Tinklenberg, J. R. Management of “bad trips” in an evolving drug scene. Journal of the American Medical Association. 213(3):422–1425, 1970.
Frosch, W. A., Robbins, E. S., & Stern, M. Untoward reactions to lysergic acid diethylamide (LSD) resulting in hospitalization. New England Journal of Medicine. 273(23): 1235–1239, 1965.
Levy, R. M. Diazepam for LSD intoxication. Lancet 1: 1297, 1971.
Woodruff, R. A., Jr., Goodwin, D. W., & Guze, S. B. Psychiatric Diagnosis. New York: Oxford University Press, 1974.
Cohen, S. (Ed.). Flashbacks. Drug Abuse and Alcoholism Newsletter. 6(9):1–3, 1977.
Forrest, J. A. H., & Tarala, R. A. 60 hospital admissions due to reactions to lysergide (LSD). Lancet. 11: 1310–1313, 1973.
Abruzzi, W. Drug-induced psychosis. International Journal of the Addictions. 12(1):183–193, 1977.
Shoichet, R. Emergency treatment of acute adverse reactions to hallucinogenic drugs. In P. G. Boume (Ed.), A Treatment Manual for Acute Drug Abuse Emergencies. Washington, D.C.: U.S. Government Printing Office, 1974, pp. 80–82.
Friedman, S. A., & Hirsh, S. E. Extreme hyperthermia after LSD ingestion. Journal of the American Medical Assocation. 217(11): 1549–1550, 1971.
Liskow, B. LSD and prolonged psychotic reactions. American Journal of Psychiatry. 128(9): 1154, 1972.
Glass, G. S., & Bowers, M. B. Chronic psychosis associated with long-term psychotomimetic drug abuse. Archives of General Psychiatry. 23: 97–102, 1970.
Ungerleider, J. T. LSD and the courts. American Journal of Psychiatry. 126(8): 1179, 1970.
Grant, I., Mohns, L., Miller, M., & Reitan, R. M. A neuropsychological study of polydrug users. Archives of General Psychiatry. 33: 973–978, 1976.
Robinson, J. T., Chitham, R. G., Greenwood, R. M., & Taylor, J. W. Chromosomal aberrations and LSD. A controlled study in 50 psychiatric patients. British Journal of Psychiatry. 125: 238–244, 1974.
Culver, C. M., & King, F. W. Neuropsychological assessment of undergraduate marihuana and LSD users. Archives of General Psychiatry. 31: 707–711, 1974.
Eller, J. L., & Morton, J. M. Bizarre deformities in offspring of user of lysergic acid diethylamide. New England Journal of Medicine. 283(8): 395–397, 1970.
Emanuel, I., & Ansell, J. S. LSD, intrauterine amputations, and amniotic-band syndrome. Lancet. July 17: 158–159, 1971.
Bloom, A. D. Peyote (mescaline) and human chromosomes. Journal of the American Medical Association. 234(3): 313, 1975.
Bozzetti, L., Jr., Goldsmith, S., & Ungerleider, J. T. The great banana peel hoax. American Journal of Psychiatry. 124(5): 132–133, 1967.
Cohen, S. (Ed.). Angel dust: The pervasive psychedelic. Drug Abuse and Alcoholism Newsletter. 5(7):1–3, 1976.
Gelenberg, A. J. Psychopharmacology update. McLean Hospital Journal. 2(2): 89–96, 1977.
Schuckit, M. A., & Morrissey, E. R. Propoxyphene and phencydidine (PCP) use in adolescents. Journal of Clinical Psychiatry. 39(1): 7–13, 1978.
Showalter, C. V., & Thornton, W. E. Clinical pharmacology of phencyclidine toxicity. American Journal of Psychiatry. 134: 1234–1238, 1977.
Cohen, S. (Ed.). PCP. New trends in treatment. Drug Abuse and Alcoholism Newsletter. 5(6):1–4, 1978.
Yesavage, J. A., & Freman, A. M. Acute PCP intoxication. Journal of Clinical Psychiatry. 39: 664–666, 1978.
Slavney, P R., Rich, G. B., Pearlson, G. D., & McHugh, P. R. Phencydidine abuse and symptomatic mania. Biological Psychiatry. 12: 697–700, 1977.
Dietz, W. H., Jr., Sr Stuart, M. J. Nutmeg and prostaglandins. New England Journal of Medicine. 294: (9): 503, 1976.
Schulze, R. G. Nutmeg as a hallucinogen. New England Journal of Medicine. 295: 174, 1976.
Faguet, R. A., Rowland, K. F. “Spice cabinet” intoxication. American Journal of Psychiatry. 135: 860–861, 1973.
Fink, P. J., Goldman, M. J., & Lyons, I. Morning glory seed psychosis. Archives of General Psychiatry. 15: 209–213, 1966.
Domino, E. F. The hallucinogens. In R. W. Richter (Ed.), Medical Aspects of Drug Abuse. New York: Harper & Row, 1975, p. 4.
Block, S. H. The grocery store high. American Journal of Psychiatry. 135(1): 126, 1978.
Brodsky, L., & Zuniga, J. Nitrous oxide: A psychotogenic agent. Comprehensive Psychiatry. 16(2): 185–188, 1975.
Nickerson, M. Vasodilator drugs. In L. S. Goodman & A. Gilman (Eds.), The Pharmacological Basis of Therapeutics. New York: Macmillan, 1965, pp. 734–738.
Cohen, S. (Ed.). Amyl nitrite rediscovered. Drug Abuse and Alcoholism Newsletter. 7(1):1–3, 1978.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1979 Plenum Publishing Corporation
About this chapter
Cite this chapter
Schuckit, M.A. (1979). The Hallucinogens, PCP, and Related Drugs. In: Drug and Alcohol Abuse. Critical Issues in Psychiatry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3542-9_8
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3542-9_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3544-3
Online ISBN: 978-1-4684-3542-9
eBook Packages: Springer Book Archive